In a Neutral regime, GENI's AIQ Score of 45/100 with Quality base of 40/100 and fading Momentum at 52/100 (Δ-15) signals mixed conviction. Wait for component alignment before adding exposure. Watch momentum trend for confirmation or fading.
Quick Stats
GENI's 7-day signal profile is softening with AIQ change of -4.0 points and momentum delta of -15.0. Trend delta is -4.00, which helps frame whether the current move is accelerating or fading.
Snapshot: Sun, 26 Jul 2026 00:00:00 GMT. Baseline: 2026-07-17.
| Date | AIQ | Mom | Val | Qual | Resilience |
|---|---|---|---|---|---|
| 2026-07-25 | 45 | 52 | 51 | 40 | 32 |
| 2026-07-18 | 49 | 67 | 51 | 40 | 32 |
| 2026-07-11 | 46 | 56 | 51 | 40 | 32 |
| 2026-07-04 | 44 | 47 | 51 | 40 | 32 |
| 2026-06-27 | 47 | 58 | 51 | 40 | 32 |
Premium Feature
Full AIQ Analysis
AIQ Intelligence
AI Analysis Report
Scenario Analysis
AIQ Scenario Builder
GENI (GENI) Stock Analysis
GENI (GENI) has an AIQ Score of 45/100 in a Neutral regime as of Jul 25, 2026. Momentum is strongest at 52/100. Risk is weakest at 32/100. The main conflict is that momentum leads at 52/100 while risk lags at 32/100.
GENI (GENI) carries an AIQ Score of 45 out of 100, placing it in a mixed signal regime for this snapshot. A mid-range reading typically means component signals are not fully aligned, so interpretation should focus on what is improving versus what is lagging.
Beta is 1.99, implying roughly 99% higher sensitivity than a broad market baseline.
In the latest weekly profile, AIQ has moved -4.0 points over the last 7 days, momentum delta is -15.0, trend delta is -4.00, risk delta is 0.0. This combination is most useful for judging whether signal quality is strengthening or fading into mean reversion.
| Evidence Layer | Public Evidence |
|---|---|
| Regime Context | GENI is in a Neutral AIQ regime with score 45/100. |
| Signal Conflict | The primary conflict is that momentum leads at 52/100 while risk lags at 32/100. |
| Factor Evidence | Momentum 52/100 · Value 51/100 · Quality 40/100 · Risk 32/100 |
| Persistence | GENI has scored AIQ 60+ in 0 of the last 60 daily snapshots. 30-day avg: 46/100. 60-day avg: 47/100. |
| Checklist | Status | Evidence |
|---|---|---|
| Factor strength | Wait | Momentum is the strongest factor at 52/100. |
| Timing | Wait | Momentum is 52/100 with 7-day delta -15.0. |
| Regime fit | Wait | GENI is in a Neutral regime at 45/100. |
| Risk control | Pass | Risk factor is 32/100 with beta of 1.99 indicates above-market sensitivity. |
| Conflict | Wait | Current conflict: momentum leads at 52/100 while risk lags at 32/100. |
GENI's 7-day signal profile is softening with AIQ change of -4.0 points and momentum delta of -15.0. Trend delta is -4.00, which helps frame whether the current move is accelerating or fading.
Signal snapshot as of Sun, 26 Jul 2026 00:00:00 GMT. 7-day comparison baseline: 2026-07-17.
| Metric | Current |
|---|---|
| AIQ Score | 45/100 |
| Price | $6.48 |
| Beta | 1.99 |
GENI vs Internet / Consumer Tech Peers
Portfolio Implication
Related Links
GENI Stock FAQ
What does the GENI AIQ Score mean?
AIQ Score summarizes multiple factors for GENI, including momentum, value, quality, and risk. Higher scores generally indicate stronger combined signals, but you should still validate with your own risk tolerance.
How often is GENI data updated?
GENI quote and scoring components refresh on the platform cadence. Always confirm timestamp freshness on-page before making time-sensitive decisions.
Should I compare GENI with an index before investing?
Yes. Comparing GENI versus benchmarks like SPY or QQQ helps you separate stock-specific strength from broader market moves.
Where can I review deeper GENI fundamentals, technicals, and risk?
Use the Fundamentals, Technicals, and Risk tabs from this page to inspect driver-level metrics behind the headline score.
How the AIQ Score Is Built
Methodology, factor weights, and how to interpret score history
Loading GENI...